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1. Disorder Labels in Medical Diagnosis 
A key step in medical diagnosis is giving the patient’s situation a label, e.g. Myocardial Infarction (MI, heart attack), or 
Appendicitis, which essentially assigns the patient to a class (or classes) of patients that are likely to have similar body 
failures and manifest similar findings (symptoms, history, physical examination, test results, etc.). Using the terminology 
of Artificial Intelligence (AI), this step is known as labeling and the medical findings are known as features. The 
classification label is not a free text written on the fly, but rather is taken from an approved list of hundreds of different 
disorder names, see ICD-10 2019, which have been compiled and refined by the medical profession over many years, 
e.g. K35.80 code for Appendicitis. In the early/intermediate stages of a diagnostic process, the list of candidate disorder 
labels that may account for the known set of findings is known by physicians as differential diagnosis, and the objective 
is to collect more findings, in a cost-effective manner, to converge to a situation where one or more labels are almost  
certain, while all others are virtually eliminated.  
It should be stressed, however, that two patients may be assigned the same label, say D17, with roughly the same 
probability, say >85%, (and every expert would agree that D17 is the right one), but with important differences in their 
list of findings that may suggest different ensuing actions, such as deviations from the template treatment plan for D17. 
Feinstein’s classic book on Clinical Judgement [1] contains excellent material on the foundations of medical diagnosis 
and disease categorization by one of the giants in medical thinking. 
2. Key Limitations of Disorder Labeling by Case-Based Machine Learning Algorithms 
AI-based software for diagnosis support started 40+ years ago and is now re-emerging with great progress due to 
machine learning’s evolution and breakthroughs, as well as increased data availability. Using AI has great potential to 
improve healthcare across the entire spectrum from clinical sessions to remote medicine. This article points at directions 
to improve the quality, depth and breadth of AI-based solutions for diagnosis support.  I was fortunate to be one of the 
pioneers in this space developing Bayesian Network algorithms for multiple co-existing disorders that were the AI core 
of MEDAS [2], [3]; a large-scale system for Emergency and Critical Care. In 1990, long after I moved on, MEDAS reached a 
“90% level agreement with the gold standard diagnosis of the attending physician” [4] and grew to cover 350 disorders 
by means of 6000 features.  More recent works on AI software are based on deep learning, random forest, gradient 
boosting, decision trees, or other case-based machine learning (ML) techniques. Evidence so far, from early and from 
recent works, strongly suggests that data-centric, and/or probability-centric, AI algorithms can reach expert level 
performance in the disorder labeling phase. However, these AI algorithms only make statistical class membership 
decisions; they do not ‘understand’ clinically what’s going on with the patient in terms of physiology/anatomy to the 
level required to decide on the right ensuing actions. Findings are represented just by codes, say X(21) for Blood 
Pressure, X(72) for ST Elevation in EKG, and there are no software representations behind them of the body failures that 
produce these findings, such as representation of the human heart with its four chamber structure,... Pure case-based 
ML algorithms are knowledge-blind.  
Statistically, a typical disorder is characterized by 30 to 90 most relevant features. For any given disorder, relatively few 
(<5%) of its characterizing features are absolutes (‘Must be’ or ‘Cannot be’), and for most individual features there is 
more than one disorder that may account for them. This is reflected in their sensitivity/specificity values that are 
somewhere between zero and one (sensitivity and specificity are related terms to true positives, false positives). 
Assuming that for a given disorder, 60 of its characterizing features have sensitivity/specificity values in that range, it 
means that there are potentially endless manifestation patterns of patients with the same disorder (2**60>10**15 = 
10,000,000,000,000,000, assuming for simplicity binary features). Not all manifestations have different ensuing actions, 
but enough of them do, due to potential complications, contradicting drugs, or just ‘watch out for’ monitoring. 
Additionally, in many cases, the labels of the primary diagnoses leave some findings un-explained. Diagnosis is not 
complete until every abnormal finding is clinically explained, at which point we assess prognosis and decide whether or 
not to take treatment actions, or/and additional tests are needed to rule out a severe problem which, currently, is still a 
remote possibility.  
Note that, in this respect, AI for medicine is unique. In many AI applications, e.g. traffic signs reading, or hand-writing 
digit recognition, once labeling the object is reached, the potential statistical variations in the object image, e.g. due to 
dirt, light conditions or hand writing, do not have impact on the implied decision of the class membership: a ‘STOP’ label 
for a traffic sign is an instruction to halt, or ‘6’ label is a numeric 6 digit in a check amount. This article discusses AI 
solutions to cover the full workflow of medical diagnosis, as opposed to individual point solutions that only address 
narrow limited task such as MRI interpretation, or interpretation of EKG, EEG signals. 
Labeling a diagnosis is a critical step and its importance should not be under-estimated. However, the ultimate goal of 
medical diagnosis is to be able to decide on the full set of the right ensuing actions to improve patient outcomes.  
So, how do physicians do it? What would it take to develop AI solutions to go beyond the labeling phase? 
3.  Physicians Leverage Knowledge of Anatomy, Physiology, and …  
Physicians leverage their knowledge of anatomy and physiology, together with cause and effect reasoning (etiology), to 
come up with a more refined diagnosis - beyond just statistical labeling – that better explains the manifestation pattern 
of any specific patient; leading to the right ensuing actions. We will call this complete diagnosis. Physicians, though, do 
not approach diagnosis as a two-phase process with labeling being phase 1. All throughout the diagnosis process, 
physicians integrate statistical considerations (sensitivity/ specificity/ incidence) with anatomy and physiology 
considerations aiming to best understand the situation of the specific patient currently being examined.  
The phrases ‘every patient is unique’ (or in statistical terms, a sample of one, N=1) is a viewpoint often represented in 
discussions on the concept of medical diagnosis. Perhaps the most salient observation supporting this notion is the place 
for Physician Notes in patient records. Patient records are written by physicians for physicians, implying that once you 
record the patient findings and the 1-5 words diagnostic label, there is no need for verbose text connecting the observed 
findings with the textbook description of the label. You are expected, though, to provide any additional useful 
information beyond the label that are unique to this specific patient and are relevant to future care. 
4. Complete Diagnosis is Results-Oriented Diagnosis  
To summarize, while labeling the diagnoses is a very important step, we cannot stop there, and we need to continue 
analyzing the patient situation until we reach a complete diagnosis. The complete diagnosis phase, beyond the labeling 
phase, is only partially a matter of extra verification, i.e. increasing the probability of the labels, notwithstanding the cost 
of excessive verification with minimal additional value. It is more the need for a broader/deeper patient assessment that 
produces specific refinements for the ensuing actions. Medical diagnosis is only partially about probability calculations 
for label X or Y. It is about clinical understanding the overall situation of the patient for the purpose of delivering the 
right treatment.  
In every profession, you are ultimately measured by the results you deliver; not by your activities along the way. 
Medicine is ultimately measured by the outcomes in patient care as a result of treatment actions. Adopting the 
outcome-orientation approach, the diagnosis phase is completed only when it enables the best decisions that the 
medical profession can offer for the specific patient under consideration with his unique set of body failures. Most 
contemporary machine Learning models in healthcare are based on patient datasets of clinical findings and aim at 
diagnostic classification of IDC-10 labels or predicting clinical values. Even when patient outcomes, benefits, cost, or re-
admission data are available, they, typically, are not included in the learning algorithms for classification or prediction of 
diagnosis. Few works discuss machine learning models for predicting outcomes, e.g. predict hospital re-admission, or in-
hospital death. A JAMA Aug 2019 [5] Viewpoint article by Shah et al eloquently describes the challenges of quantitative 
models to measure the impact of classification machine learning models on the actions taken by the physicians to 
improve patient care. It also includes references on recent works. 
5. Beyond Knowledge-Blind Algorithms  
Early successes with Deep Learning led to overstating its applicability, reaching claims such as ‘with sufficient amount of 
data, Deep Learning can solve all AI problems’. Assuming gigantic patient datasets, can a Deep Learning algorithm learn 
from patient data ONLY the anatomy and physiology of the human heart? That is: learn the four chamber structure, the 
arteries, the valves, the conduction system and the pacemaker, the walls, …, the function of each module and the overall 
blood flow. I doubt it, simply because patient data does not contain the information to enable such learning. (To 
appreciate the complexity, check here for an excellent heart simulation). Architecturally, the input into case-based 
learning are flat vectors. Representing knowledge about body organs requires far more complex structures the like of 
engineering design diagrams or state machines (state charts) for real-time systems. On top of these knowledge 
structures we will need to add evidential and cause-and-effect reasoning; two areas where current data-centric machine 
learning algorithms have inherent limitations, as they are only based on reasoning by similarity and extrapolation, Pearl 
[6].  
By analogy, with data about billions of “things”, and thousands of apples that fall down every day, deep learning 
algorithms, with no human touch, can certainly come up with a model to calculate the time at which any given falling 
object will touch the ground. But can data-only deep learning model come up with Newton’s laws? I mean produce 
models that represent deeper generalized understanding of the Universe forces along with “compact” formula such as 
Time to hit the ground=SQRT(2*Height/g), where g=gravity=9.8m/s2 (as opposed to a gigantic black box neural net)? 
Machines can learn many things from data, but data is not the only source that machines can learn from. Historic 
patient data only tells us what the possible manifestations of a certain body failure are. Anatomy and physiology 
knowledge tell us how the body works and fails. Both are needed for complete diagnosis.  
With the understanding that disorder labeling via ML and medical diagnosis are not quite the same, I propose the Double 
Deep Learning [7] approach which advocates integrating machine-teaching of deep knowledge with contemporary 
data-only machine-self-learning techniques.  The term ‘deep knowledge’ refers to the difference between teaching 
physicians versus teaching paramedics, where, with physicians, we teach deep fundamental principles, and models, like 
anatomy and physiology and the necessary parts of chemistry and biology. This enables deeper reasoning beyond 
reasoning by similarity and extrapolation of contemporary data-centric knowledge-blind machine learning algorithms. 
Machine-teaching of deep knowledge is also in contrast to teaching shallow prescriptive knowledge in the form of 
explicit IF-THEN rules connecting facts to conclusions that characterized the classic rule-based systems of the early AI 
days. Way back (1978), I discussed the limitations of rule-based systems specifically in the context of medical diagnosis 
applications [8].  
Additionally, by their very nature, statistics-based machine learning algorithms entail error probabilities which, for 
complex cases, could be quite high. Reducing this error probability by adding to AI systems reasoning which is based on 
complimentary knowledge sources could benefit greatly the diagnostic accuracy of the labeling phase and, as explained 
above, the depth and breadth of the complete diagnosis. 
6. Wikipedia for Smart Machines 
In [7] I propose an initiative to build Wikipedia for Smart Machines, meaning targeting readers that are not human, but 
rather smart machines. Named ReKopedia, e.g. Medical ReKopedia, the goal is to develop methodologies, tools, and 
algorithms to convert medical knowledge that we learn in schools, universities and during our professional life into 
Reusable Knowledge structures that smart machines can use in their inference algorithms. Ideally, ReKopedia would be 
an open source shared knowledge repository similar to the well-known shared open source software code repositories. 
Reviewing the syllabuses of schools and universities in different areas will teach us the content we teach humans and 
can be a good starting point for the content we should teach machines. For medicine, the Physiome Project is a great 
initiative to develop standards, models and databases for computational modelling of human organs. See for instance, 
the 2016 special edition of The Journal of Physiology [9] which focuses on the Cardiac Physiome Project and provides 
additional references.  The results coming out from this important project, with human as target readers, could be a 
great source for structuring medical knowledge into Medical ReKopedia modules to be used by AI algorithms in medical 
support systems.  Investment in the ReKopedia initiative has tremendous value for society, because once knowledge 
packages for smart machines exist, an unlimited number of computers that use it can be operational in seconds. To 
produce an expert physician requires nine months followed by at least 30 years, and then all is gone after a limited, and 
unpredictable, number of years.  
7.   Summary 
To summarize, data-centric machine learning algorithms have a convincing proven record, will continue to evolve, and 
have their place in the architecture of every AI solution for medical decision support. Nonetheless, like any other 
mathematical technique, they have their limitations and applicability scope. The goal of this article is to complement 
them with techniques to overcome their inherent limitations as knowledge-blind algorithms. The Double Deep Learning 
approach, along with the initiative for Wikipedia for smart machines, leads to AI diagnostic support solutions for 
Complete Diagnosis beyond the limited data-only labeling solutions we see today. The clinical value and business value 
of AI systems for medicine will forever be limited until they also ‘understand’ the content we teach medical students in 
universities. 
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